StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO)

Equities research analysts at StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note issued on Wednesday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

Shares of T2 Biosystems stock opened at $0.12 on Wednesday. The company’s fifty day simple moving average is $0.16 and its two-hundred day simple moving average is $0.71. T2 Biosystems has a 12-month low of $0.06 and a 12-month high of $6.80.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.